Targeting genes in living mammals by RNA interference

Briefings in Functional Genomics

Volumn 10, Issue 4, 2011, Pages 238-247

  Podolska, Katerina ^a   Svoboda, Petr ^b  

^a Laboratory of Petr Svoboda   (Czech Republic)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

RNAi; shRNA; siRNA; Therapy

Indexed keywords

ADENOVIRUS VECTOR; DNA FRAGMENT; DOUBLE STRANDED RNA; LENTIVIRUS VECTOR; LIPID; MESSENGER RNA; SHORT HAIRPIN RNA; TRANSCRIPTASE; VIRUS RNA;

ARTICLE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENE SILENCING; GENE TARGETING; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C VIRUS; HOMOZYGOSITY; HYDRODYNAMICS BASED TRANSFECTION; KNOCKOUT GENE; MAMMAL; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RNA INTERFERENCE; RNA SEQUENCE; TRANSGENE; TRANSGENIC MOUSE; TRANSGENICS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; GENE KNOCKDOWN TECHNIQUES; GENE THERAPY; MAMMALS; RNA INTERFERENCE;

ANIMALIA; EUKARYOTA; MAMMALIA;

EID: 80051902207     PISSN: 20412649     EISSN: 20412657     Source Type: Journal    
DOI: 10.1093/bfgp/elr013     Document Type: Article

References (93)

1. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 2009;136:642-55.
2. Ghildiyal M, Zamore PD. Small silencing RNAs: an expanding universe. Nat Rev Genet 2009;10:94-108.
3. Doench JG, Petersen CP, Sharp PA. siRNAs can function as miRNAs. Genes Dev 2003;17:438-42.
4. Gantier MP, Williams BR. The response of mammalian cells to double-stranded RNA. Cytokine Growth Factor Rev 2007;18:363-71.
5. Yang S, Tutton S, Pierce E, et al. Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol Cell Biol 2001;21:7807-16.
6. Watanabe T, Totoki Y, Toyoda A, et al. Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature 2008;453:539-43.
7. Tam OH, Aravin AA, Stein P, et al. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature 2008;453:534-8.
8. Ohnishi Y, Totoki Y, Toyoda A, etal. Small RNA class transition from siRNA/piRNA to miRNA during preimplantation mouse development. Nucleic Acids Res 2010; 38:5141-51.
9. Babiarz JE, Ruby JG, Wang Y, et al. Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor independent, Dicer-dependent small RNAs. Genes Dev 2008;22:2773-85.
10. Svoboda P, Stein P, Hayashi H, et al. Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference. Development 2000;127:4147-56.
11. Wianny F, Zernicka-Goetz M. Specific interference with gene function by double-stranded RNA in early mouse development. Nat Cell Biol 2000;2:70-5.
12. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-8.
13. Fewell GD, Schmitt K. Vector-based RNAi approaches for stable, inducible and genome-wide screens. Drug Discov Today 2006;11:975-82.
14. Peng S, York JP, Zhang P. A transgenic approach for RNA interference-based genetic screening in mice. Proc Natl Acad Sci USA 2006;103:2252-6.
15. Svoboda P. RNA silencing in mammalian oocytes and early embryos. Curr Top Microbiol Immunol 2008;320:225-56.
16. Svoboda P. Preparation of dsRNA for microinjection experiments in mouse. Cold Spring Harb Protoc 2009; pdb.prot5131.
17. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002;296:550-3.
18. McManus MT, Petersen CP, Haines BB, et al. Gene silencing using micro-RNA designed hairpins. RNA 2002;8:842-50.
19. Paddison PJ, Caudy AA, Bernstein E, et al. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002;16:948-58.
20. van de Wetering M, Oving I, Muncan V, etal. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 2003;4:609-15.
21. Seibler J, Kuter-Luks B, Kern H, et al. Single copy shRNA configuration for ubiquitous gene knockdown in mice. Nucleic Acids Res 2005;33:e67.
22. Wooddell CI, Van Hout CV, Reppen T, et al. Long-term RNA interference from optimized siRNA expression constructs in adult mice. Biochem Biophys Res Commun 2005;334: 117-27.
23. Coumoul X, Shukla V, Li C, et al. Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference. Nucleic Acids Res 2005;33:e102.
24. Fritsch L, Martinez LA, Sekhri R, et al. Conditional gene knock-down by CRE-dependent short interfering RNAs. EMBO Rep 2004;5:178-82.
25. Sternberg N, Hamilton D. Bacteriophage P1 site-specific recombination. I. Recombination between lox P sites. J Mol Biol 1981;150:467-86.
26. Zeng Y, Wagner EJ, Cullen BR. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell 2002;9:1327-33.
27. Chung KH, Hart CC, Al-Bassam S, et al. Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res 2006;34: e53.
28. Stegmeier F, Hu G, Rickles RJ, et al. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc Natl Acad Sci USA 2005;102:13212-7.
29. Xu Z, Williams CJ, Kopf GS, et al. Maturation-associated increase in IP3 receptor type 1: role in conferring increased IP3 sensitivity and Ca2+ oscillatory behavior in mouse eggs. Dev Biol 2003;254:163-71.
30. Dickins RA, McJunkin K, Hernando E, et al. Tissue-specific and reversible RNA interference in transgenic mice. Nat Genet 2007;39:914-21.
31. Hasuwa H, Kaseda K, Einarsdottir T, et al. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett 2002;532:227-30.
32. Rubinson DA, Dillon CP, Kwiatkowski AV, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003;33:401-6.
33. Hitz C, Wurst W, Kuhn R. Conditional brain-specific knockdown of MAPK using Cre/loxP regulated RNA interference. Nucleic Acids Res 2007;35:e90.
34. Hohenstein P, Slight J, Ozdemir DD, et al. High-efficiency Rosa26 knock-in vector construction for Cre-regulated overexpression and RNAi. Pathogenetics 2008;1:3.
35. Carmell MA, Zhang L, Conklin DS, et al. Germline transmission of RNAi in mice. Nat Struct Biol 2003;10:91-2.
36. Kunath T, Gish G, Lickert H, et al. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat Biotechnol 2003;21:559-61.
37. Nagy A, Rossant J, Nagy R, et al. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci USA 1993;90:8424-8.
38. Lickert H, Takeuchi JK, Von Both I, etal. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 2004;432:107-12.
39. Brummelkamp TR, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002;2:243-7.
40. Hemann MT, Fridman JS, Zilfou JT, et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet 2003;33: 396-400.
41. Boden D, Pusch O, Lee F, et al. Efficient gene transfer of HIV-1-specific short hairpin RNA into human lymphocytic cells using recombinant adeno-associated virus vectors. Mol Ther 2004;9:396-402.
42. Stewart SA, Dykxhoorn DM, Palliser D, et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 2003;9:493-501.
43. Tiscornia G, Singer O, Ikawa M, etal. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci USA 2003;100:1844-8.
44. Bjork BC, Fujiwara Y, Davis SW, et al. A transient transgenic RNAi strategy for rapid characterization of gene function during embryonic development. PLoS One 2010;5: e14375.
45. Gupta S, Schoer RA, Egan JE, et al. Inducible, reversible, and stable RNA interference in mammalian cells. Proc Natl Acad Sci USA 2004;101:1927-32.
46. Wang J, Tekle E, Oubrahim H, etal. Stable and controllable RNA interference: Investigating the physiological function of glutathionylated actin. Proc Natl Acad Sci USA 2003;100: 5103-6.
47. Coumoul X, Li W, Wang RH, et al. Inducible suppression of Fgfr2 and Survivin in ES cells using a combination of the RNA interference (RNAi) and the Cre-LoxP system. Nucleic Acids Res 2004;32:e85.
48. Kasim V, Miyagishi M, Taira K. Control of siRNA expression using the Cre-loxP recombination system. Nucleic Acids Res 2004;32:e66.
49. Ventura A, Meissner A, Dillon CP, et al. Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl Acad Sci USA 2004;101:10380-5.
50. Chang HS, Lin CH, Chen YC, et al. Using siRNA technique to generate transgenic animals with spatiotemporal and conditional gene knockdown. Am J Pathol 2004;165: 1535-41.
51. Timmons L, Fire A. Specific interference by ingested dsRNA. Nature 1998;395:854.
52. Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-11.
53. Orii H, Mochii M, Watanabe K. A simple 'soaking method' for RNA interference in the planarian Dugesia japonica. Dev Genes Evol 2003;213:138-41.
54. Newmark PA, Reddien PW, Cebria F, et al. Ingestion of bacterially expressed double-stranded RNA inhibits gene expression in planarians. Proc Natl Acad Sci USA 2003; 100(Suppl. 1):11861-5.
55. Lohmann JU, Endl I, Bosch TC. Silencing of developmental genes in Hydra. Dev Biol 1999;214:211-4.
56. Bucher G, Scholten J, Klingler M. Parental RNAi in Tribolium (Coleoptera). Curr Biol 2002;12:R85-6.
57. Amdam GV, Norberg K, Page RE, Jr, et al. Downregulation of vitellogenin gene activity increases the gustatory responsiveness of honey bee workers (Apis mellifera). Behav Brain Res 2006;169:201-5.
58. Whangbo JS, Hunter CP. Environmental RNA interference. Trends Genet 2008;24:297-305.
59. Kawakami S, Hashida M. Targeted delivery systems of small interfering RNA by systemic administration. Drug Metab Pharmacokinet 2007;22:142-51.
60. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999;6:1258-66.
61. Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999;10:1735-7.
62. Giladi H, Ketzinel-Gilad M, Rivkin L, et al. Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther 2003;8:769-76.
63. Lewis DL, Hagstrom JE, Loomis AG, et al. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 2002;32:107-8.
64. McCaffrey AP, Meuse L, Pham TT, et al. RNA interference in adult mice. Nature 2002;418:38-9.
65. McCaffrey AP, Nakai H, Pandey K, et al. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 2003;21:639-44.
66. Song E, Lee SK, Wang J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003;9: 347-51.
67. Lewis DL, Wolff JA. Systemic siRNA delivery via hydrodynamic intravascular injection. Adv Drug Deliv Rev 2007; 59:115-23.
68. Sorensen DR, Leirdal M, Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol Biol 2003;327:761-6.
69. Gao K, Huang L. Nonviral methods for siRNA delivery. Mol Pharm 2009;6:651-8.
70. Ge Q, Filip L, Bai A, et al. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad SciUSA 2004;101:8676-81.
71. Kong XC, Barzaghi P, Ruegg MA. Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference. EMBORep 2004;5:183-8.
72. Massaro D, Massaro GD, Clerch LB. Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice. Am J Physiol Lung Cell Mol Physiol 2004;287: L1066-70.
73. Salahpour A, Medvedev IO, Beaulieu JM, et al. Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals. Biol Psychiatry 2007;61:65-9.
74. Aouadi M, Tesz GJ, Nicoloro SM, et al. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 2009;458:1180-4.
75. Golzio M, Mazzolini L, Moller P, et al. Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery. Gene Ther 2005;12:246-51.
76. Kishida T, Asada H, Gojo S, et al. Sequence-specific gene silencing in murine muscle induced by electroporation-mediated transfer of short interfering RNA. J GeneMed 2004;6:105-10.
77. Matsuda T, Cepko CL. Electroporation and RNA interference in the rodent retina in vivo and in vitro. ProcNatlAcad SciUSA 2004;101:16-22.
78. Akaneya Y, Jiang B, Tsumoto T. RNAi-induced gene silencing by local electroporation in targeting brain region. JNeurophysiol 2005;93:594-602.
79. Konishi Y, Stegmuller J, Matsuda T, et al. Cdh1-APC controls axonal growth and patterning in the mammalian brain. Science 2004;303:1026-30.
80. Paganin-Gioanni A, Bellard E, Couderc B, et al. Tracking in vitro and in vivo siRNA electrotransfer in tumor cells. JRNAi Gene Silencing 2008;4:281-8.
81. Chen Y, Chen H, Hoffmann A, et al. Adenovirus-mediated small-interference RNA for in vivo silencing of angiotensin AT1a receptors in mouse brain. Hypertension 2006;47: 230-7.
82. Chetty C, Bhoopathi P, Joseph P, et al. Adenovirusmediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice. Mol Cancer Ther 2006;5:2289-99.
83. Kargiotis O, Chetty C, Gondi CS, et al. Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma. Oncogene 2008;27:4830-40.
84. Arts GJ, Langemeijer E, Tissingh R, etal. Adenoviral vectors expressing siRNAs for discovery and validation of gene function. Genome Res 2003;13:2325-32.
85. Shen C, Buck AK, Liu X, et al. Gene silencing by adenovirus-delivered siRNA. FEBS Lett 2003;539:111-4.
86. Zhao LJ, Jian H, Zhu H. Specific gene inhibition by adenovirus-mediated expression of small interfering RNA. Gene 2003;316:137-41.
87. Oliveira DM, Goodell MA. Transient RNA interference in hematopoietic progenitors with functional consequences. Genesis 2003;36:203-8.
88. Leung RK, Whittaker PA. RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol Ther 2005; 107:222-39.
89. Castanotto D, Rossi JJ. The promises and pitfalls of RNA-interference-based therapeutics. Nature 2009;457: 426-33.
90. Tiemann K, Rossi JJ. RNAi-based therapeutics-current status, challenges and prospects. EMBO Mol Med 2009;1: 142-51.
91. Lorenz C, Hadwiger P, John M, et al. Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells. Bioorg Med Chem Lett 2004;14:4975-7.
92. Chang J, Guo JT, Jiang D, et al. Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. J Virol 2008;82:8215-23.
93. Henke JI, Goergen D, Zheng J, et al. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 2008;27:3300-10.